Delivery Order SPE2DB22D3501-SPE2DB25FVU17
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $31,487.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,771 units of Candesartan Cilexetil 16 mg tablets. The contract has a completion date of January 3, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) that Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Candesartan Cilexetil 16 MG tablets in 90-count packages, with a ceiling value of $7,044.06 and a performance period through April 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $7,188.72 and an ultimate completion date of February 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Candesartan Cilexetil 16 mg tablets, a pharmaceutical product used in the treatment of hypertension and heart failure. The contract has a ceiling value of $11,747.16 and a period of performance through May 13, 2025. This contract is not designated as a set-aside and was awarded on...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Candesartan Cilexetil 32 mg tablets. The contract has a ceiling value of $5,251.22 and a performance period ending on May 27, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $2,277.09 and a period of performance ending on August 2, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,264.64 delivery order is for the supply of Candesartan Cilexetil 32 mg tablets, with a completion date of May 15, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $18,672.16, is for the delivery of Candesartan Cilexetil 16 mg tablets. It is a firm fixed-price contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,034.78, is for the delivery of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has a ceiling value of $1,787.82 and a completion date of April 22, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...